研究者
J-GLOBAL ID：202101016315668350   更新日: 2024年01月30日

石井 貴大

Ishii Takahiro
競争的資金等の研究課題 (1件)：
  • 2021 - 2023 潰瘍性大腸炎の発癌サーベイランスを目的とした分子病理学的解析
論文 (5件)：
  • Takahiro Ishii, Ayako Suzuki, Takeshi Kuwata, Shoshi Hisamitsu, Hiroko Hashimoto, Yuuki Ohara, Kazuyoshi Yanagihara, Shuichi Mitsunaga, Takayuki Yoshino, Takahiro Kinoshita, et al. Drug-exposed cancer-associated fibroblasts facilitate gastric cancer cell progression following chemotherapy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. 2021. 24. 4. 810-822
  • Takahiro Ishii, Yoshiaki Nakamura. [Precision Medicine for Advanced Solid Malignancies Based on Circulating Tumor DNA Analysis]. Gan to kagaku ryoho. Cancer & chemotherapy. 2020. 47. 12. 1645-1652
  • Genichiro Ishii, Takahiro Ishii. Review of cancer-associated fibroblasts and their microenvironment in post-chemotherapy recurrence. Human cell. 2020. 33. 4. 938-945
  • Takahiro Ishii, Akihito Kawazoe, Akinori Sasaki, Saori Mishima, Sawada Kentaro, Yoshiaki Nakamura, Daisuke Kotani, Yasutoshi Kuboki, Hiroya Taniguchi, Takashi Kojima, et al. Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer. Therapeutic advances in medical oncology. 2020. 12. 1758835920942377-1758835920942377
  • Takahiro Ishii, Akihito Kawazoe, Kohei Shitara. Dawn of precision medicine on gastric cancer. International journal of clinical oncology. 2019. 24. 7. 779-788
MISC (1件)：
  • Masataka Yagisawa, Kentaro Sawada, Yoshiaki Nakamura, Takahiro Ishii, Yohei Kubota, Hiromichi Nakajima, Tomoko Jogo, Akinori Sasaki, Saori Mishima, Daisuke Kotani, et al. Molecular landscape and prognostic value of HER2 low-expression on metastatic colorectal cancer. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 4
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM